???pagination.result.count???
???pagination.result.page???
1
A Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and β-Cell Growth. , Kim HY ., Endocrinol Metab (Seoul). September 1, 2014; 29 (3): 320-7.
Synaptic scaffolding molecule binds to and regulates vasoactive intestinal polypeptide type-1 receptor in epithelial cells. , Gee HY., Gastroenterology. August 1, 2009; 137 (2): 607-17, 617.e1-4.
Rapid, nongenomic responses to ecdysteroids and catecholamines mediated by a novel Drosophila G-protein-coupled receptor. , Srivastava DP., J Neurosci. June 29, 2005; 25 (26): 6145-55.
Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. , Hallows KR., Am J Physiol Cell Physiol. May 1, 2003; 284 (5): C1297-308.
Serum- and glucocorticoid-dependent kinase, cell volume, and the regulation of epithelial transport. , Fillon S., Comp Biochem Physiol A Mol Integr Physiol. October 1, 2001; 130 (3): 367-76.
The Xenopus proglucagon gene encodes novel GLP-1-like peptides with insulinotropic properties. , Irwin DM., Proc Natl Acad Sci U S A. July 22, 1997; 94 (15): 7915-20.
Regulation of the CFTR chloride channel from humans and sharks. , Hanrahan JW., J Exp Zool. July 1, 1996; 275 (4): 283-91.
Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents. , Fulmer SB., Proc Natl Acad Sci U S A. July 18, 1995; 92 (15): 6832-6.
Expression of cystic fibrosis transmembrane regulator Cl- channels in heart. , Levesque PC., Circ Res. October 1, 1992; 71 (4): 1002-7.